Windlas Biotech Limited (WINDLAS) — Corporate Action | 1 July 2026
Windlas Biotech announced its 25th AGM on July 23, 2026, with a record date of July 16, 2026, to determine shareholders eligible for a recommended dividend of Rs. 6.30 per share, representing 126% on a Rs. 5 face value, for the financial year 2025-26.
About Windlas Biotech Limited (WINDLAS)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when WINDLAS files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track WINDLAS — Free💡 Ask AI about this filing
📊 More WINDLAS filings
- Announcement — 11 August 2026 Windlas Biotech announced that the audio recording of its investor conference call discussing unaudi...
- 🟡 Board Meeting — 10 August 2026 Windlas Biotech's board approved unaudited Q1 FY26 results showing revenue of **₹2,532.12 crores**, ...
- 🔴 Financial Results — 10 August 2026 Windlas Biotech Limited reported record Q1 FY27 revenue of **₹248 crores**, up 18% YoY, driven by st...
- Announcement — 10 August 2026 Windlas Biotech reported 18% YoY revenue growth to Rs 248 crore in Q1 FY27, driven by 84% contributi...
- 🔴 Financial Results — 24 July 2026 No summary available
🔥 Also filed on 1 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when WINDLAS files new disclosures
Track WINDLAS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track WINDLAS — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research